2018
DOI: 10.1080/10903127.2018.1484968
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Three Junctional Tourniquets Using a Randomized Trial Design

Abstract: All JTQ devices performed poorly during transport. Combined, present findings highlight the potential of JTQ products for saving lives threatened by junctional wounds, but also highlight the need for specific product improvements towards fostering JTQ performance in patient transport.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 19 publications
0
17
0
Order By: Relevance
“…Of the 14 studies included for JTQ review, eight were conducted in 194 healthy human volunteers [16][17][18][19][20][21][22][23] (Table 2), 3 were conducted on 16 perfused human cadavers [24][25][26] (Table 3), and 2 case series [27,28] and 1 case report [29] on 21 trauma patients (Table 4). The total number of cadavers and volunteers was 210.…”
Section: Pre-hospital Feasability Evidencementioning
confidence: 99%
See 2 more Smart Citations
“…Of the 14 studies included for JTQ review, eight were conducted in 194 healthy human volunteers [16][17][18][19][20][21][22][23] (Table 2), 3 were conducted on 16 perfused human cadavers [24][25][26] (Table 3), and 2 case series [27,28] and 1 case report [29] on 21 trauma patients (Table 4). The total number of cadavers and volunteers was 210.…”
Section: Pre-hospital Feasability Evidencementioning
confidence: 99%
“…Device efficacy was reported in all 11 studies involving cadavers or volunteers and ranged from 11-100% across all four JTQs. The efficacy of the CRoC ranged from 84-100% [18,19,[21][22][23][24][25]; the AAJT ranged from 11-100% [16][17][18][19][20][21]; JETT had an efficacy range from 75-100% [18,19,21,23,25], and the SJT ranged from 82-100% [18,19,[21][22][23]26]. Only one study assessed the efficacy of the SJT, JETT, and CRoC during the transport in volunteers, ranging from 24-48%.…”
Section: Pre-hospital Feasability Evidencementioning
confidence: 99%
See 1 more Smart Citation
“…In recent years, several cases reported applying new hemostatic devices, such as AAJT TM CRoC TM JETT TM SAM-JT TM , among patients with junctional hemorrhage in the prehospital settings [5][6][7][8] . However, the effectiveness was only at 24 48% [9] in the pre-hospital and the transport process. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is an emerging strategy for junctional hemostasis and has been applied in the pre-hospital settings.…”
Section: Introductionmentioning
confidence: 96%
“…The emergence of EHCDs, such as combat ready clamp (CRoC), abdominal aortic and junctional tourniquet (AAJT) and SAM junctional tourniquet (SJT), has changed the dilemma of ineffective control of NCTH within battle elds or extreme environments, providing the possibility for further reducing the rate of killed in action (KIA) (6,7). However, too broad of a pressurized area and ambiguous vascular locating methods are ubiquitous among existing EHCDs, often resulting in excessive peripheral tissue/organ compression or high compression segments of targeted arteries.…”
mentioning
confidence: 99%